Follow Us
© 2026 Arizent. All rights reserved.
Yes. When you compare the cost of other health care options under consideration as well as the cost to all of us for care for the un or under insured (which is passed on in the form of higher health care costs), the COBRA subsidy idea is worth investigating.
For reprint and licensing requests for this article, click here.
Employers face another steep rise in healthcare expenses in 2027, prompting a closer look at GLP-1 coverage, pharmacy spending and high-cost conditions.
Public sectors are approaching chronic disease support out of necessity, leading to benefits that build a stronger workforce.
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.
Multiple experts weigh in on the challenges and considerations benefit leaders need to keep in mind as they make decisions about medication coverage.
Employers are increasingly exploring lifestyle spending accounts as a way to deliver health and wellness flexibility to a workforce demanding it.
